Class 2 Medicines Recall: GL Pharma GmbH, Oxylan 40mg prolonged-release tablets, EL (20)A/41

GL Pharma is recalling a specific batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution during routine stability testing.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 1 September 2020

• Message type: Medicines recall/notification
• Medical specialty: Pharmacy
• Issued: 1 September 2020

MDR Number

MDR 158-08/20

Company Name

GL Pharma GmbH

Product description

Oxylan 40mg prolonged-release tablets, PL 21597/0064

Batch Number	Expiry Date	Pack Size	First Distributed
9F119A	31/05/2024	56	02/06/2020

Active pharmaceutical ingredient: oxycodone hydrochloride

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Further information

For medical information enquiries please contact pv@gl-pharma.at

For stock control enquiries please contact david.hammond@healthcarepharma.co.uk

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.

NHS England and NHS Improvement Regional Offices are asked to forward this alert to community pharmacy contractors.

Download document

EL (20)A/41

Published 1 September 2020